Faruqi and Faruqui, LLP Logo
Share this page

Tenet Healthcare Corp. (THC)

NYSE:THC

Summary

Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Tenet Healthcare Corp. To Contact The Firm Before Lead Plaintiff Deadline

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Tenet Healthcare Corp. (“Tenet Healthcare” or the “Company”) (NYSE:THC) of the December 6, 2016 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers.

The lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of all those who purchased Tenet Healthcare securities between February 28, 2012 and October 3, 2016 (the “Class Period”).  The case, Nicholas Pennington v. Tenet Healthcare Corporation et al, No. 2:16-cv-07510 was filed on October 7, 2016, and has been assigned to Judge George H. Wu.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failed to disclose that: (1) Tenet Healthcare illegally paid kickbacks to induce the referral of patients to the Company’s hospitals for labor and delivery; (2) through this, Tenet Healthcare defrauded the Georgia Medicaid program; and (3) as a result, the Company's statements about the its business, operations and prospects were materially false and misleading and/or lacked a reasonable basis.

Specifically, during aftermarket hours on August 1, 2016, the Company issued a press release announcing it had reached an agreement with the U.S. government to resolve a criminal investigation and civil litigation in connection with the aforementioned allegations.

On this news, Tenet Healthcare’s share price fell from $28.91 per share on August 1, 2016 to a closing price of $27.57 on August 2, 2016—a $1.34 or a 4.64% drop.

In addition, on October 3, 2016, the Company issued a press release announcing it had finalized an agreement with the U.S. government to resolve the aforementioned investigation and litigation.

On this news, Tenet Healthcare’s share price fell from $22.66 per share on September 30, 2016 to a closing price of $21.75 on October 3, 2016—a $0.91 or a 4.02% drop.

Take Action

If you invested in Tenet Healthcare stock or options between February 28, 2012 and October 3, 2016 and would like to discuss your legal rights, please fill out the form below. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.  Faruqi & Faruqi, LLP also encourages anyone with information regarding Tenet Healthcare’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Request Information

Please tell us about yourself by completing the form and we will provide you with additional
information on how to join the Class Action at no cost to you.

  • Case:
    Tenet Healthcare Corp. (THC)
  •    

* The submission of this form does not create an attorney-client relationship.

Contact Counsel

Richard W. Gonnello
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330

Email:

Case Details

Date:

  • 10/12/2016

Class Period:

  • 02/28/2012 - 10/03/2016

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.